IQ-AI Limited

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, EMIS.L has a market cap of 1.2B. Regarding current trading prices, IQAI.L is priced at £0.83, while EMIS.L trades at £1,922.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas EMIS.L's P/E ratio is 40.89. In terms of profitability, IQAI.L's ROE is -0.89%, compared to EMIS.L's ROE of +0.24%. Regarding short-term risk, IQAI.L is more volatile compared to EMIS.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, 0MSD.L has a market cap of 1.1B. Regarding current trading prices, IQAI.L is priced at £0.83, while 0MSD.L trades at £41.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas 0MSD.L's P/E ratio is 28.74. In terms of profitability, IQAI.L's ROE is -0.89%, compared to 0MSD.L's ROE of +0.04%. Regarding short-term risk, IQAI.L is more volatile compared to 0MSD.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, CRW.L has a market cap of 717.9M. Regarding current trading prices, IQAI.L is priced at £0.83, while CRW.L trades at £2,050.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas CRW.L's P/E ratio is 66.13. In terms of profitability, IQAI.L's ROE is -0.89%, compared to CRW.L's ROE of +0.05%. Regarding short-term risk, IQAI.L is more volatile compared to CRW.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, INS.L has a market cap of 199.4M. Regarding current trading prices, IQAI.L is priced at £0.83, while INS.L trades at £829.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas INS.L's P/E ratio is 59.21. In terms of profitability, IQAI.L's ROE is -0.89%, compared to INS.L's ROE of +0.09%. Regarding short-term risk, IQAI.L is more volatile compared to INS.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, SMD.L has a market cap of 79.7M. Regarding current trading prices, IQAI.L is priced at £0.83, while SMD.L trades at £58.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas SMD.L's P/E ratio is -14.50. In terms of profitability, IQAI.L's ROE is -0.89%, compared to SMD.L's ROE of -0.23%. Regarding short-term risk, Volatility data is not available for a full comparison. IQAI.L has daily volatility of 4.34 and SMD.L has daily volatility of N/A.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, KOO.L has a market cap of 59.9M. Regarding current trading prices, IQAI.L is priced at £0.83, while KOO.L trades at £167.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas KOO.L's P/E ratio is 7.98. In terms of profitability, IQAI.L's ROE is -0.89%, compared to KOO.L's ROE of +0.29%. Regarding short-term risk, IQAI.L is more volatile compared to KOO.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, RENX.L has a market cap of 24M. Regarding current trading prices, IQAI.L is priced at £0.83, while RENX.L trades at £7.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas RENX.L's P/E ratio is -0.60. In terms of profitability, IQAI.L's ROE is -0.89%, compared to RENX.L's ROE of +2.96%. Regarding short-term risk, IQAI.L is less volatile compared to RENX.L. This indicates potentially lower risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, COG.L has a market cap of 15.7M. Regarding current trading prices, IQAI.L is priced at £0.83, while COG.L trades at £37.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas COG.L's P/E ratio is -7.50. In terms of profitability, IQAI.L's ROE is -0.89%, compared to COG.L's ROE of -0.69%. Regarding short-term risk, IQAI.L is more volatile compared to COG.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, INHC.L has a market cap of 9M. Regarding current trading prices, IQAI.L is priced at £0.83, while INHC.L trades at £9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas INHC.L's P/E ratio is -3.25. In terms of profitability, IQAI.L's ROE is -0.89%, compared to INHC.L's ROE of -0.27%. Regarding short-term risk, IQAI.L is more volatile compared to INHC.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, FDBK.L has a market cap of 6.5M. Regarding current trading prices, IQAI.L is priced at £0.83, while FDBK.L trades at £14.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas FDBK.L's P/E ratio is -0.61. In terms of profitability, IQAI.L's ROE is -0.89%, compared to FDBK.L's ROE of -0.34%. Regarding short-term risk, IQAI.L is more volatile compared to FDBK.L. This indicates potentially higher risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, TRLS.L has a market cap of 1.3M. Regarding current trading prices, IQAI.L is priced at £0.83, while TRLS.L trades at £0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas TRLS.L's P/E ratio is -0.20. In terms of profitability, IQAI.L's ROE is -0.89%, compared to TRLS.L's ROE of -0.38%. Regarding short-term risk, IQAI.L is less volatile compared to TRLS.L. This indicates potentially lower risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, DVRG.L has a market cap of 1.2M. Regarding current trading prices, IQAI.L is priced at £0.83, while DVRG.L trades at £0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas DVRG.L's P/E ratio is -0.15. In terms of profitability, IQAI.L's ROE is -0.89%, compared to DVRG.L's ROE of -0.14%. Regarding short-term risk, IQAI.L is less volatile compared to DVRG.L. This indicates potentially lower risk in terms of short-term price fluctuations for IQAI.L.

IQAI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IQAI.L stands at 2M. In comparison, SENS.L has a market cap of 0. Regarding current trading prices, IQAI.L is priced at £0.83, while SENS.L trades at £0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IQAI.L currently has a P/E ratio of N/A, whereas SENS.L's P/E ratio is N/A. In terms of profitability, IQAI.L's ROE is -0.89%, compared to SENS.L's ROE of -0.57%. Regarding short-term risk, IQAI.L is less volatile compared to SENS.L. This indicates potentially lower risk in terms of short-term price fluctuations for IQAI.L.